These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. Widner B; Leblhuber F; Fuchs D J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858 [TBL] [Abstract][Full Text] [Related]
30. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032 [TBL] [Abstract][Full Text] [Related]
39. Enhanced degradation of tryptophan in patients on hemodialysis. Koenig P; Nagl C; Neurauter G; Schennach H; Brandacher G; Fuchs D Clin Nephrol; 2010 Dec; 74(6):465-70. PubMed ID: 21084050 [TBL] [Abstract][Full Text] [Related]
40. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Kato A; Suzuki Y; Suda T; Suzuki M; Fujie M; Takita T; Furuhashi M; Maruyama Y; Chida K; Hishida A Hemodial Int; 2010 Oct; 14(4):418-24. PubMed ID: 20673309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]